Latest Financial Results

Q2 2018

Quarterly Results

Ended Apr 30, 2018

Stock Information

Symbol

ITUS

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

Logo Itus

Latest News & Events

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

Read More...

ITUS to Ring the NASDAQ Closing Bell on July 5th

Read More...

ITUS Accelerates Schedule for its CAR T Therapy and Provides Update

Read More...

Cancer Fact: Approximately 40 million mammograms are conducted annually.